Loading...

MERCK Kommanditgesellschaft auf Aktien

MKKGYPNK
Healthcare
Drug Manufacturers - Specialty & Generic
$27.62
$0.21(0.77%)
U.S. Market opens in 14h 21m

MERCK Kommanditgesellschaft auf Aktien (MKKGY) Stock Overview

Explore MERCK Kommanditgesellschaft auf Aktien’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap60B
P/E Ratio19.52
EPS (TTM)$1.40
ROE0.09%
Fundamental Analysis

AI Price Forecasts

1 Month$25.93
3 Months$32.20
1 Year Target$25.08

MKKGY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of MERCK Kommanditgesellschaft auf Aktien (MKKGY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 63.96, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $25.08.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 19.52 and a market capitalization of 60B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.70%
5-Day Change
4.56%
1-Month Change
12.34%
3-Month Change
-8.08%
6-Month Change
1.74%
Year-to-Date (YTD) Change
-3.76%
1-Year Change
4.72%
3-Year Change
-23.43%
5-Year Change
-21.94%
All-Time (Max) Change
128.88%

Contact Information

49 6151 72 0
Frankfurter Strasse 250, Darmstadt, NaN, 64293

Company Facts

59,020 Employees
IPO DateNov 16, 2007
CountryDE
Actively Trading

Frequently Asked Questions